Topics
LSX USA Congress 2026
Conference Name: LSX USA Congress 2026
Time: September 22-24, 2026
Location: Hynes Convention Center, Boston, USA
Axcelead Drug Discovery Partners, Inc. is a Gold Sponsor of LSX USA Congress 2026 and will be exhibiting at the event in Boston, MA, USA. Visit us at Booth #1 to learn how we can empower your drug discovery. Let’s connect in the partneringONE system to discuss more details. Our team looks forward to meeting you there!

Akito Hata
VP, Head of Discovery Technologies Business Unit, Axcelead Drug Discovery Partners, Inc.
- Drug discovery scientist specializing in in vitro biology and high-throughput screening
- Joined Axcelead in 2021 and contributed to kinase inhibitor and targeted protein degradation platforms
- Previously worked at Takeda in Japan and Boston across small molecule, antibody, and cell therapy programs

Yasushi Fujitani, PhD
Senior Director, Drug Discovery Project Direction, Axcelead Drug Discovery Partners, Inc.
- >25 years of experience of Drug Discovery Research in Novartis and Takeda and 5 years of experience in Medical Affairs in Takeda and Gilead
- Possesses expertise as a pharmacologist and has experience leading multiple drug discovery projects from early to late stages in multiple therapeutic indications

Saomi Murai, PhD
Director, Global Business Development, Axcelead Drug Discovery Parners, Inc.
- 20 years of drug discovery experience, with expertise in molecular biology, pharmacology, and oncology
- Former Global Project Lead for oncology programs at Takeda, spanning early discovery through preclinical development
- Leads global business development at Axcelead, building strategic partnerships with pharmaceutical and biotechnology companies
